| ²é¿´: 234 | »Ø¸´: 3 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
¾²6873ľ³æ (³õÈëÎÄ̳)
|
[½»Á÷]
ÇóÖú£ºÖÐÒëÓ¢~
|
||
|
ÉúÎïÀûÓöÈÊÇÆÀ¼ÛÖÆ¼ÁÖÊÁ¿ºÍÈ·¶¨¸øÒ©Í¾¾¶µÄÖØÒª²ÎÊýÖ®Ò»¡£ÉúÎïÀûÓöȵÄÔ¤²âÓкܶàÖÖ·½·¨£¬ÀýÈç·ÅÉäÐÔ±ê¼Ç·¨£¬ºÐÊÒ¸øÒ©·¨µÈ¡£ºÐʽ¸øÒ©·¨Êǽ«¶àÖÖÒ©Îïͬʱ¸øÓèÿֻ¶¯Î°´³£¹æÈ¡Ñùʱ¼ä£¬ÔËÓÃHPLC/MSÁªÓü¼Êõ½øÐÐÑùÆ·´¦Àí·ÖÎö£¬ÊÇÒ»ÖÖ¸ßͨÁ¿Ò©ÎïɸѡµÄ·½·¨¡£Ä¿Ç°ºÐʽ¸øÒ©·¨µÄÓ¦Óò¢²»¹ã·º£¬Òò´Ë¾ßÓйãÀ«µÄÑо¿¿Õ¼ä¡£±¾ÎľͺÐʽ¸øÒ©·¨Ô¤²âÈ˿ڷþÉúÎïÀûÓöȵÄÏÖ×´ºÍ½øÕ¹×÷Ò»¼òÒª¸ÅÊö¡£ [ Last edited by ¾²6873 on 2009-2-12 at 22:28 ] |
» ²ÂÄãϲ»¶
287·ÖÇóµ÷¼Á ÓÐרÀû¹ú½±Ò»Ö¾Ô¸¹þ¹¤´ó085406
ÒѾÓÐ4È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
085405Èí¼þ¹¤³Ì301·ÖÇóµ÷¼Á£¬×¨Ë¶¿É¿çרҵ£¬ËÄÁù¼¶Òѹý
ÒѾÓÐ3È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
274Çóµ÷¼ÁÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Çóµ÷¼Áµ½²ÄÁÏ
ÒѾÓÐ5È˻ظ´
²ÄÁÏ¿¼ÑÐÇóµ÷¼Á×Ü·Ö280
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸Ö£ÖÝ´óѧ²ÄÁÏÓ뻯¹¤085600£¬Çóµ÷¼Á
ÒѾÓÐ27È˻ظ´
»¯¹¤Çóµ÷¼Á£¡
ÒѾÓÐ11È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
¶«´óÍõ
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 8206.7
- É¢½ð: 21
- ºì»¨: 1
- Ìû×Ó: 389
- ÔÚÏß: 49.6Сʱ
- ³æºÅ: 425922
- ×¢²á: 2007-07-28
- ÐÔ±ð: GG
- רҵ: ½ðÊô²ÄÁϵÄÖÆ±¸¿ÆÑ§Óë¿çѧ
2Â¥2009-02-12 22:43:10
¾²6873
ľ³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1498
- É¢½ð: 3
- Ìû×Ó: 50
- ÔÚÏß: 30.4Сʱ
- ³æºÅ: 659914
- ×¢²á: 2008-11-22
- ÐÔ±ð: MM
- רҵ: Ò©¼Áѧ
3Â¥2009-02-12 23:42:50
wshbinzhang
Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)
- ·ÒëEPI: 3
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 7807.3
- É¢½ð: 200
- Ìû×Ó: 5830
- ÔÚÏß: 153.7Сʱ
- ³æºÅ: 478725
- ×¢²á: 2007-12-14
- רҵ: ½á¹¹ÌÕ´É
¡ï ¡ï ¡ï ¡ï
¾²6873(½ð±Ò+4,VIP+0):лл²ÎÓë~ 2-14 09:55
¾²6873(½ð±Ò+4,VIP+0):лл²ÎÓë~ 2-14 09:55
|
Bioavailability is one of the most important parameters to evaluate pharmaceutical preparation quality and determine administration approach. Bioavailability can be predicted using various methods. Up to now, xx has not been widely employed; therefore, intensive research is necessary. This paper summarizes the current situations and developments about oral administration of bioavailability for human. |
4Â¥2009-02-13 15:42:24














»Ø¸´´ËÂ¥